Poly Medicure Ltd. (BSE: 531768) is a New Delhi, Delhi-based company in the Medical Consumables industry. With a market capitalisation of ₹16,168 Cr, it ranks #426 by market cap among the 6,137 Indian listed companies on FinBizNet, and #1 of 13 in Medical Consumables. At ₹1,444.00 (as of 25 Oct 2026), the share price is 31.1% below its 52-week high of ₹2,094.30 and 22.2% above its 52-week low of ₹1,182.00. The share price is down 24.8% over one year and down 13.2% over three months.
| Current Price | ₹1,444.00 |
|---|---|
| Market Cap | ₹16,168 Cr |
| BSE Code | 531768 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Medical Consumables |
| P/E Ratio | 48.9 |
| Return on Equity | 10.84% |
| Return on Assets | 5.78% |
| 52-Week Range | ₹1,182.00 – ₹2,094.30 |
| 1-Year Price Change | -24.8% |
| 3-Month Price Change | -13.2% |
| Beta (1Y) | 0.16 |
| Dividend Yield | 0.23% |
| Headquarters | New Delhi, Delhi |
| Website | www.polymedicure.com |
| Revenue | ₹525 Cr |
|---|---|
| Net Profit | ₹84 Cr |
| Net Margin | 15.9% |
| EPS (Basic) | ₹8.49 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access
1. Medical Devices-This segment engages in the manufacture and sale of medical devices. It offers IV based infusion therapy devices, central venous access catheters, urine collection bags, and anesthesia devices.
1. Manufacture and Sale of Medical Devices-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Poly Medicure Ltd. | ₹16,168 Cr | 48.9 | 10.84% | ₹525 Cr | -24.8% |
| Q-Line Biotech Limited | ₹1,467 Cr | 17.8 | — | — | — |
| Laxmi Dental Limited | ₹1,015 Cr | 34.7 | 12.77% | ₹75 Cr | -46.3% |
| Prevest Denpro Ltd | ₹490 Cr | 23.7 | 17.79% | — | -27.8% |
| Choksi Imaging Ltd. | ₹122 Cr | 22.8 | 13.51% | — | +131.2% |
| GSM Foils Limited | ₹94 Cr | 5 | — | ₹97 Cr | -70.6% |
| Mohini Health & Hygiene Ltd | ₹57 Cr | -3.4 | 5.69% | — | -44.8% |
| Amkay Products Limited | ₹50 Cr | 21.7 | — | — | +24.4% |
| KMS Medisurgi Limited | ₹44 Cr | 179.5 | — | — | +5.0% |
Listed by market capitalisation. Ratios are shown for context only.
Poly Medicure Ltd. is trading at ₹1,444.00, with a market capitalisation of ₹16,168 Cr.
Poly Medicure Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).
Poly Medicure Ltd. has a P/E of 48.9 and a return on equity of 10.84%.
Poly Medicure Ltd. is listed on the BSE under the scrip code 531768.
Poly Medicure Ltd.'s share price is down 24.8% over one year and down 13.2% over three months. Its 52-week range is ₹1,182.00 to ₹2,094.30.
In Q1 FY27, Poly Medicure Ltd. reported revenue of ₹525 Cr and net profit of ₹84 Cr, with basic EPS of ₹8.49 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.